Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Pariente

Showing results (181-190 of 220) with videos related to

Pageof 22
Sort By:
Dementia and Geriatric Cognitive Disorders|October 24, 2008
Primary and secondary care consultations in elderly demented individuals in France. Results from the Three-City StudyCatherine Helmer, Karine Pérès, Antoine Pariente, et al.
Drug Safety|May 17, 2022
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance DataGuillaume L Martin, Julien Jouganous, Romain Savidan, et al.
British Journal of Clinical Pharmacology|April 18, 2018
Patterns of antidepressant use during pregnancy: a nationwide population-based cohort studyAnne Bénard-Laribière, Elodie Pambrun, Anne-Laure Sutter-Dallay, et al.
Pharmacoepidemiology and Drug Safety|January 27, 2017
Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndromeJulien Bezin, Rolf H H Groenwold, M Sanni Ali, et al.
Journal of the American Medical Informatics Association : JAMIA|December 1, 2012
Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR projectPaul Avillach, Jean-Charles Dufour, Gayo Diallo, et al.
Pharmacoepidemiology and Drug Safety|November 21, 2012
Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in FranceNicholas Moore, Sinem Ezgi Gulmez, Dominique Larrey, et al.
Clinical Pharmacology and Therapeutics|April 18, 2021
Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug ReactionsLouis Létinier, Julien Jouganous, Mehdi Benkebil, et al.
Therapie|March 13, 2019
Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in FranceAnne Bénard-Laribière, Pernelle Noize, Pierre-Oliver Girodet, et al.
Therapie|April 3, 2023
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspectiveFrancesco Salvo, Antoine Pariente, Marie Blanche Valnet-Rabier, et al.
Fundamental & Clinical Pharmacology|January 6, 2022
Spontaneous reporting of adverse drug reactions as an outlet for patient dismay? The case of Levothyrox® change of excipientsSerena Romani, Audrey Fresse, Nadège Parassol-Girard, et al.
Pageof 22

Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
Dementia and Geriatric Cognitive Disorders|October 24, 2008
Primary and secondary care consultations in elderly demented individuals in France. Results from the Three-City StudyCatherine Helmer, Karine Pérès, Antoine Pariente, et al.
Drug Safety|May 17, 2022
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance DataGuillaume L Martin, Julien Jouganous, Romain Savidan, et al.
British Journal of Clinical Pharmacology|April 18, 2018
Patterns of antidepressant use during pregnancy: a nationwide population-based cohort studyAnne Bénard-Laribière, Elodie Pambrun, Anne-Laure Sutter-Dallay, et al.
Pharmacoepidemiology and Drug Safety|January 27, 2017
Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndromeJulien Bezin, Rolf H H Groenwold, M Sanni Ali, et al.
Journal of the American Medical Informatics Association : JAMIA|December 1, 2012
Design and validation of an automated method to detect known adverse drug reactions in MEDLINE: a contribution from the EU-ADR projectPaul Avillach, Jean-Charles Dufour, Gayo Diallo, et al.
Pharmacoepidemiology and Drug Safety|November 21, 2012
Choice of the denominator in case population studies: event rates for registration for liver transplantation after exposure to NSAIDs in the SALT study in FranceNicholas Moore, Sinem Ezgi Gulmez, Dominique Larrey, et al.
Clinical Pharmacology and Therapeutics|April 18, 2021
Artificial Intelligence for Unstructured Healthcare Data: Application to Coding of Patient Reporting of Adverse Drug ReactionsLouis Létinier, Julien Jouganous, Mehdi Benkebil, et al.
Therapie|March 13, 2019
Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in FranceAnne Bénard-Laribière, Pernelle Noize, Pierre-Oliver Girodet, et al.
Therapie|April 3, 2023
Role of spontaneous reporting in investigating the relationship between mRNA COVID-19 vaccines and myocarditis: The French perspectiveFrancesco Salvo, Antoine Pariente, Marie Blanche Valnet-Rabier, et al.
Fundamental & Clinical Pharmacology|January 6, 2022
Spontaneous reporting of adverse drug reactions as an outlet for patient dismay? The case of Levothyrox® change of excipientsSerena Romani, Audrey Fresse, Nadège Parassol-Girard, et al.
Pageof 22